Search Results - "Mañé, J. M."

Reversible liver toxicity with adjuvant trastuzumab for localized breast cancer by Muñoz, A., Carrera, S., Ferreiro, J., Ruiz de Lobera, A., Mañé, J.M., López-Vivanco, G.

Get full text

Tumor lysis syndrome in a multiple myeloma treated with thalidomide by Fuente, N., Mañe, J. M., Barcelo, R., Muñoz, A., Perez-Hoyos, T., Lopez-Vivanco, G.

Get full text

Distal ischemic changes related to combination chemotherapy with cisplatin and gemcitabine: Description of four cases by Barceló, R., López-Vivanco, G., Mañé, J. M., Rubio, I., Muñoz, A., Fernández, R.

Get full text

Sequential dose-dense paclitaxel followed by topotecan in untreated extensive-stage small-cell lung cancer: a Spanish Lung Cancer Group phase II study by Felip, E., Rosell, R., Domine, M., Santomé, L., Garrido, P., Font, A., Carrato, A., Terrasa, J., Vadell, C., Mañe, J. M., Baselga, J.

“…Background: Poor survival rates in extensive-stage small-cell lung cancer (SCLC) patients prompted us to evaluate a sequential dose-dense schedule of…”
Get full text

Carboplatin plus ftorafur as a palliative treatment in locally advanced cancer of the oral cavity and lip by Grau, J J, Palombo, H, Estapé, J, Mañé, J M, Blanch, J L, Vilalta, A, Castro, V, Biete, A

“…Forty consecutive patients with local advanced cancer of the oral cavity and lip, heavily pretreated, were palliated with two courses of carboplatin, 400 mg/m2…”
Get more information

A novel biweekly schedule with cisplatin and gemcitabine in advanced non-small cell lung cancer by López-Vivanco, G, Fuente, N, Barceló, R, Rubio, I, Muñoz, A, Mañé, J M, Pérez-Hoyos, T, Viteri, A, Ferreiro, J

“…A new schedule with cisplatin and gemcitabine administered biweekly was prospectively evaluated in stage IIIB or IV non-small cell lung cancer. We report the…”
Get more information

Cancer diagnosis disclosure in a Spanish hospital by Estapé, J, Palombo, H, Hernández, E, Daniels, M, Estapé, T, Grau, J J, Viñolas, N, Mañé, J M

“…At the Clinic Hospital in Barcelona, Spain, 167 cancer patients and 380 hospital health care workers were interviewed about cancer diagnosis disclosure. Only…”
Get more information

CYFRA 21-1 in lung cancer: comparison with CEA, CA 125, SCC and NSE serum levels by Molina, R, Agusti, C, Mañe, J M, Filella, X, Jo, J, Joseph, J, Giménez, N, Estapé, J, Ballesta, A M

“…CYFRA 21-1, CEA, CA 125, SCC and NSE serum levels were determined in 50 healthy subjects and in 189 patients with primary lung cancer (101 with locoregional…”
Get more information

Chronic oral etoposide in advanced breast cancer by PALOMBO, H, ESTAPE, J, VINOLAS, N, GRAU, J. J, MANE, J. M, DANIELS, M, MELLADO, B

“…Chronic oral etoposide has shown activity in some metastatic refractory tumors. To test its activity in previously treated metastatic breast cancer patients,…”
Get full text

Age and Clinical Characteristics of 1433 Patients with Lung Cancer by MAñÉ, JOAN M., ESTAPÉ, JORDI, SÁNCHEZ-LLORET, JOAN, GRAU, JUAN J., PALOMBO, HUGO, AGUSTI, CARLES, MELLADO, BEGOÑA

“…A review has been conducted of 1433 patients treated by the Lung Cancer Unit of our hospital to assess the association of age with clinical characteristics of…”
Get full text

Concomitant radiotherapy (RT) with docetaxel for unresectable locally advanced non-small cell lung cancer (LA-NSCLC) by Fuente, N., Mañé, J. M., Rubio, I., Carrera, S., Martínez-Bueno, A., de Argumedo, G. López, Ferreiro, J., Abón, G., Garrido, P., López-Vivanco, G.

“…Abstract only…”
Get full text

Folfiri-bevacizumab as first line treatment for advanced colorectal cancer (ACRC): Results from 77 consecutive unsellected patients by de Lobera, A. Ruiz, Mañé, J. M., López-Vivanco, G., Muñoz, A., de Argumedo, G. López, Ferreiro, J., de Corcuera, I. Diaz, Fuente, N., Moreno, A., Rubio, I.

“…Abstract only…”
Get full text

Toxicity of bevacizumab (BV) in metastatic colorectal carcinoma (MCRC): Analysis in 173 consecutive patients by Ferreiro, J., de Corcuera, I. Diaz, Mañé, J. M., Sancho, A., Muñoz, A., Fuente, N., de Argumedo, G. López, Moreno, A., Rubio, I., de Lobera, A. Ruiz

“…Abstract only…”
Get full text

Onycholysis Associated With Capecitabine in Combination With Irinotecan in Two Patients With Colorectal Cancer by Muñoz, Alberto, Barceló, Ramón, Rubio, Itziar, Mañé, Joan Manuel, Ferreiro, Josefa, López-Vivanco, Guillermo

“…We want to call attention to this in-frequent toxicity because of the expanding role of capecitabine-based regimens for the adjuvant and palliative treatment…”
Get full text

Gemcitabine and vascular toxicity by Muñoz, A, Mañé, J.M, Rubio, I, Fernández, R, Fuente, N, Barceló, R, Vivanco, G.López

Get full text

Hydrocortisone anaphylaxis: a new case report by Corominas, N, Mañé, J M, Codina, C, Paz, M A, Ribas, J

“…In this report we describe a case of a nonatopic patient who developed an anaphylactoid reaction immediately after receiving intravenous hydrocortisone. The…”
Get more information

Oxaliplatin and capecitabine after gemcitabine failure in patients with advanced pancreatic, biliary, and gallbladder adenocarcinoma (APBC) by Sancho, A., López-Vivanco, G., de Corcuera, I. Diaz, Ferreiro, J., Moreno, A., Mielgo, X., Fernandez, R., Ancizar, N., Iruarrizaga, E., Mañe, J. M.

“…Abstract only…”
Get full text

Addisonian crisis as first manifestation of adrenal gland insufficiency in patient diagnosed with lung cancer by Muñoz, A, Oñate, J, Mañé, J M, Rubio, I, Fernández, R, Barceló, J R, López Vivanco, G

“…Adrenal insufficiency or Addison's disease is actually a rare illness associated with numerous pathologies. We describe the case of a fifty years old male with…”
Get full text

First-line docetaxel (Dx) and capecitabine (Cap) in advanced head and neck cancer by Gil-Negrete, A., Mañe, J. M., Ruiz de Lobera, A., Martinez-Bueno, A., Rubio, I., Fuente, N., Lopez-Vivanco, G., Ancizar, N., Fernandez, R., Sancho, A.

“…Abstract only 16505 Background: Dx and Cap are useful drugs in head and neck cancer. Our purpose was to establish the efficacy and safety of this combination…”
Get full text

Nasopharyngeal carcinoma: Comparison of concomitant chemoradiotherapy with neoadjuvant chemotherapy in the caucasian population by Sancho, A., Rubio, I., Diaz de Corcuera, I., Munoz, A., Martinez-Bueno, A., Mane, J. M., Ruiz de Lobera, A., Fernandez-Rodriguez, R., Gil-Negrete, A., Carrera, S.

“…Abstract only 16532 Background: Nowadays, concomitant chemoradiotherapy (CT-RT) is the standard treatment for nasopharyngeal carcinoma (NPC). Neoadyuvant…”
Get full text